Growth Metrics

Arcturus Therapeutics Holdings (ARCT) Current Leases (2019 - 2025)

Historic Current Leases for Arcturus Therapeutics Holdings (ARCT) over the last 7 years, with Q3 2025 value amounting to $4.1 million.

  • Arcturus Therapeutics Holdings' Current Leases rose 2000.0% to $4.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.1 million, marking a year-over-year increase of 2000.0%. This contributed to the annual value of $3.6 million for FY2024, which is 1756.79% down from last year.
  • Arcturus Therapeutics Holdings' Current Leases amounted to $4.1 million in Q3 2025, which was up 2000.0% from $4.0 million recorded in Q2 2025.
  • In the past 5 years, Arcturus Therapeutics Holdings' Current Leases ranged from a high of $4.3 million in Q4 2023 and a low of $1.4 million during Q2 2021
  • Over the past 5 years, Arcturus Therapeutics Holdings' median Current Leases value was $3.8 million (recorded in 2022), while the average stood at $3.3 million.
  • As far as peak fluctuations go, Arcturus Therapeutics Holdings' Current Leases soared by 15509.1% in 2022, and later crashed by 1821.43% in 2024.
  • Over the past 5 years, Arcturus Therapeutics Holdings' Current Leases (Quarter) stood at $1.5 million in 2021, then soared by 152.7% to $3.9 million in 2022, then rose by 10.94% to $4.3 million in 2023, then decreased by 17.57% to $3.6 million in 2024, then rose by 16.05% to $4.1 million in 2025.
  • Its Current Leases stands at $4.1 million for Q3 2025, versus $4.0 million for Q2 2025 and $3.7 million for Q1 2025.